Skip to main content
. 2021 Jul 14;30(161):200300. doi: 10.1183/16000617.0300-2020

FIGURE 2.

FIGURE 2

Numbers representing European Medicines Agency approved drugs within their substance class in lung oncology. Blue: chemotherapy (CT); green: targeted agents (tyrosine kinase inhibitors); red: VEGF-inhibitors; yellow: immune checkpoint inhibitors. VEGF: vascular endothelial growth factor.